Analysts Favor Selective Stock Picks Over Broad Market Calls

On Thursday, October 1, 2026, U.S. analysts provided a mixed outlook on the market, favoring company-specific opportunities over broad bullish calls. The latest updates revealed significant adjustments in price targets and ratings across various sectors. Notably, regional banks and financial services faced cuts in targets, while technology hardware and software saw several upgrades.

Accenture (ACN) received contrasting views, with Evercore setting a price target of $250.00 with an Outperform rating, while Jefferies reiterated a Hold rating. Hewlett Packard Enterprise (HPE) drew attention with multiple upgrades, including Barclays raising its target to $83.00 and Citigroup to $92.00, both maintaining positive ratings. Jabil (JBL) also saw mixed adjustments, with Barclays lowering its target to $378.00 and JPMorgan raising it to $430.00, both maintaining Overweight ratings.

In the energy sector, BP (BP) was downgraded to Neutral by BTIG and initiated with a Hold rating by Needham. ExxonMobil (XOM) faced a downgrade from Overweight to Equal Weight by Wells Fargo, with a new price target of $182.00. The biotechnology sector showed mixed movements, with upgrades for BeOne Medicines (ONC) and Kura Oncology (KURA), while AxoGen (AXGN) saw a target cut to $53.00 by Truist.

The updates reflect a selective market outlook, with analysts focusing on individual company prospects rather than broad sector trends. This nuanced approach suggests a cautious optimism, emphasizing the importance of detailed stock analysis in the current economic climate.